Established in 2013 as a separate company following the spin-off of Abbott Laboratories, AbbVie Inc. is a research-driven biopharmaceutical company headquartered in North Chicago, Illinois, U.S.A. Since its formation, AbbVie has built a broad portfolio spanning immunology, oncology, neuroscience, eye care, aesthetics, and other specialty areas, combining focused innovation with global commercial scale. The company employs approximately 57,000 people in more than 70 countries, its products reach patients in more than 175 countries, and it reported full-year net revenues of $61.160 billion for 2025.
Updated 2026-03-19